Advanced Search

National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 1) (PB 2 of 2016)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 2 of 2016
National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 1)
National Health Act 1953
I, JULIANNE QUAINE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 25 January 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JULIANNE QUAINE
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2016 (No. 1).
            (2)        This Instrument may also be cited as PB 2 of 2016.
2          Commencement
            This Instrument commences on 1 February 2016.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1] Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)
omit from the column headed “Claimed Price”:          3.93        substitute:             4.31
[2] Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)
omit from the column headed “Claimed Price”:          5.99        substitute:             6.55
[3] Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          4.41        substitute:             4.83
[4] Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          5.96        substitute:             6.74
[5] Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30
omit from the column headed “Claimed Price”:          8.91        substitute:             8.94
[6] Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30
omit from the column headed “Claimed Price”:          10.48     substitute:             10.52
[7] Schedule 1, entry for Lansoprazole in the form Tablet 15 mg (orally disintegrating)
omit from the column headed “Claimed Price”:          9.12        substitute:             11.88
[8] Schedule 1, entry for Lansoprazole in the form Tablet 30 mg (orally disintegrating)
omit from the column headed “Claimed Price”:          13.42     substitute:             16.17
[9] Schedule 1, entry for Sertraline in each of the forms: Tablet 50 mg (as hydrochloride); and Tablet 100 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          6.27        substitute:             8.22
[10]         Schedule 1, entry for Sumatriptan in the form Tablet 50 mg (as succinate) [Pricing Quantity/Pack Quantity: 2]
omit from the column headed “Claimed Price”:          4.05        substitute:             4.87
[11]         Schedule 1, entry for Sumatriptan in the form Tablet (fast disintegrating) 50 mg (as succinate)
omit from the column headed “Claimed Price”:          4.05        substitute:             4.87
 
[12]         Schedule 1, after entry for Tamoxifen
insert:
Telmisartan
Tablet 40 mg
Oral
Micardis
28
3.75
5.25

 
Tablet 80 mg
Oral
Micardis
28
10.86
12.36

Telmisartan with amlodipine
Tablet 40 mg-5 mg (as besylate)
Oral
Twynsta
28
6.84
8.34

 
Tablet 40 mg-10 mg (as besylate)
Oral
Twynsta
28
8.01
9.51

 
Tablet 80 mg-5 mg (as besylate)
Oral
Twynsta
28
16.85
18.35

 
Tablet 80 mg-10 mg (as besylate)
Oral
Twynsta
28
18.02
19.52

Telmisartan with hydrochlorothiazide
Tablet 40 mg-12.5 mg
Oral
Micardis Plus 40/12.5
28
5.25
6.75

 
Tablet 80 mg-12.5 mg
Oral
Micardis Plus 80/12.5
28
13.12
14.62

 
Tablet 80 mg-25 mg
Oral
Micardis Plus 80/25
28
14.23
15.73